Zimmer Biomet HoldingsXSWX:ZBH 65 OCF Margin % is 17.22% as of Mar. 2026, which is 16% below its 10-year median of 20.45. GuruFocus rates XSWX:ZBH with a GF Score™ of 65/100 and a GF Value™ of CHF97.46 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Zimmer Biomet Holdings ranks better than 78.4% on this metric.
The historical rank and industry rank for Zimmer Biomet Holdings's OCF Margin % or its related term are showing as below:
XSWX:ZBH'
s OCF Margin % Range Over the Past 10 Years
Min: 18.51 Med: 20.45 Max: 22.03
Current: 19.9
During the past 13 years, the highest OCF Margin % of Zimmer Biomet Holdings was 22.03%. The lowest was 18.51%. And the median was 20.45%.
XSWX:ZBH's OCF Margin % is ranked better than 78.4% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs XSWX:ZBH: 19.90
Zimmer Biomet Holdings OCF Margin % Related Terms
Zimmer Biomet Holdings OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:ZBH vs PEN, GMED, STE: OCF Margin % Comparison
For the Medical Devices subindustry, Zimmer Biomet Holdings's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zimmer Biomet Holdings OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Zimmer Biomet Holdings's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zimmer Biomet Holdings (XSWX:ZBH) has a OCF Margin % of 17.22% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zimmer Biomet Holdings and its competitors. This is 16% below median its historical median of 20.45. Over the past decade, Zimmer Biomet Holdings' OCF Margin % has ranged from 18.51 to 22.03. According to the industry distribution chart, Zimmer Biomet Holdings ranks #176 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 21.6%.
Is Zimmer Biomet Holdings' OCF Margin % too high?
Zimmer Biomet Holdings' current OCF Margin % of 17.22% is 16% below median its 10-year median of 20.45. Over the past 10 years, this metric has ranged from a low of 18.51 to a high of 22.03. The Medical Devices & Instruments industry median OCF Margin % is 5.86. Zimmer Biomet Holdings' value of 17.22% is 193.9% above this industry median. Based on the distribution chart, Zimmer Biomet Holdings ranks #176 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Zimmer Biomet Holdings has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' OCF Margin % compare to PEN and GMED?
According to the Medical Devices & Instruments industry distribution chart, Zimmer Biomet Holdings ranks #176 out of 815 companies for OCF Margin %. This places Zimmer Biomet Holdings in the top 22% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.86. Zimmer Biomet Holdings' value of 17.22% is 193.9% above this benchmark. Historically, Zimmer Biomet Holdings' own OCF Margin % has ranged from 18.51 to 22.03 over the past decade. While the company's 10-year median is 20.45 vs. the industry median of 5.86, Zimmer Biomet Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zimmer Biomet Holdings's current OCF Margin % of 17.22% is 193.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Zimmer Biomet Holdings and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zimmer Biomet Holdings's current OCF Margin % is 17.22%, which is 16% below median its own 10-year median of 20.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Based on GuruFocus' analysis, Zimmer Biomet Holdings (XSWX:ZBH) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF97.46, compared to a current price of CHF70.00 — trading 28.2% below its estimated fair value. The current OCF Margin % is 17.22%, which is 16% below median its 10-year median of 20.45 and 193.9% above the Medical Devices & Instruments industry median of 5.86. Zimmer Biomet Holdings' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current OCF Margin % is 17.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?
Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued.
The current stock price of CHF70.00 is trading 28.2% below its estimated GF Value™ of CHF97.46.
GuruFocus considers Zimmer Biomet Holdings to be Modestly Undervalued.
Key valuation signals for XSWX:ZBH:
OCF Margin %: 17.22% (16% below median its 10-year median of 20.45)
GF Value™: CHF97.46 vs. price of CHF70.00 (28.2% below fair value)
Industry Position: 193.9% above the Medical Devices & Instruments median (#176 of 815)
No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
65GF Score
Get the complete analysis for XSWX:ZBH
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:ZBH has been successfully added to your 
